Literature DB >> 15890979

Statin-mediated inhibition of Rho: only to get more NO?

Ralf P Brandes.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15890979     DOI： 10.1161/01.RES.0000168040.70096.2a

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

Review 1.  Cognitive effects of statin medications.

Authors:  Brendan J Kelley; Stephen Glasser
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

2.  The interplay of cyclic stretch and vascular endothelial growth factor in regulating the initial steps for angiogenesis.

Authors:  Justin R Wilkins; Daniel B Pike; Christopher C Gibson; Li Li; Yan-Ting Shiu
Journal:  Biotechnol Prog       Date:  2014-11-13

Review 3.  Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.

Authors:  Pei-Suen Tsou; Andrew J Haak; Dinesh Khanna; Richard R Neubig
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

Review 4.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

5.  Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta.

Authors:  Ruqin Kou; Juliano Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

Review 6.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

7.  Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism.

Authors:  Yuan Xiao; Yuhua Li; Jing Han; Yan Pan; Lu Tie; Xuejun Li
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells.

Authors:  Yoshiki Nakashima; Chika Miyagi-Shiohira; Hirofumi Noguchi; Takeshi Omasa
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

9.  Molecular Regulation of the RhoGAP GRAF3 and Its Capacity to Limit Blood Pressure In Vivo.

Authors:  Rachel A Dee; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.